If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Biography

Alan Trounson is Emeritus Professor Monash University and Distinguished Scientist, Hudson Institute for Medical Research, Clayton, Victoria, Australia. He is the past President of the Californian Institute for Regenerative Medicine (2007-2014) the Californian state’s $3 billion stem cell agency driving research in stem cell biology and facilitating the translation of stem cell discoveries into clinical therapies.

He was a pioneer of human in vitro fertilisation (IVF) (1977-1996), introducing fertility drugs for controlling ovulation, embryo freezing techniques, egg and embryo donation methods, early sperm microinjection methods, initiated embryo biopsy, developing in vitro oocyte maturation methods and the vitrification of eggs and embryos.

He was appointed Director of the Centre for Early Human Development at Monash University in 1986 and Deputy Director/Director of the Monash Institute for Reproduction and Development (1990-2003) He led the Australian team for the discovery of human embryonic stem cells in the late 1990’s and was awarded the first Australian Biotechnology of Excellence and was the founding CEO of the Australian Stem Cell Centre. He founded the Monash Immunology and Stem Cell Laboratories (MISCL) at Monash University (2004-7)

He is presently the founding CEO/President of the start-up company Cartherics Pty Ltd developing Chimeric Antigen Receptor Technology (CAR-T)/T Cell Receptor (TCR) therapies using induced Pluripotent Stem Cells (iPSCs) as an off-the shelf approach for treating cancer. Cartherics is sited on the 7th Floor of the Translation Research Facility Building, Monash Medical Centre, Clayton, Victoria.

External positions

CEO, Cartherics Pty Ltd

Keywords

  • Stem Cell Therapy
  • Immune System
  • Cancer Therapeutics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2022

Research Output 1980 2018

Improving access to ART in low-income settings through knowledge transfer: a case study from Zimbabwe

Hammarberg, K., Trounson, A., McBain, J., Matthews, P., Robertson, T., Robertson, F., Magli, C., Mhlanga, T., Makurumure, T. & Marechera, F., 1 Sep 2018, In : Human Reproduction Open. 8, 4, p. 1-5 5 p., hoy017.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Combining hiPSCs and Human Genetics: Major Applications in Drug Development

Zhang, J., Li, H., Trounson, A., Wu, J. C. & Nioi, P., 3 Aug 2017, In : Cell Stem Cell. 21, 2, p. 161-165 5 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Costs of IVF in Australia: Downward trends shall continue

Trounson, A. & Hammarberg, K., 11 Sep 2017, BioNews.

Research output: Other contributionOther

Open Access

Potential pitfall of pluripotent stem cells

Trounson, A., 3 Aug 2017, In : New England Journal of Medicine. 377, 5, p. 490-491 2 p.

Research output: Contribution to journalShort SurveyOtherpeer-review

Preferential selection and transfer of euploid noncarrier embryos in preimplantation genetic diagnosis cycles for reciprocal translocations

Wang, L., Shen, J., Cram, D. S., Ma, M., Wang, H., Zhang, W., Fan, J., Gao, Z., Zhang, L., Li, Z., Xu, M., Leigh, D. A., Trounson, A. O., Liu, J. & Yao, Y., Oct 2017, In : Fertility and Sterility. 108, 4, p. 620-627 8 p.

Research output: Contribution to journalArticleResearchpeer-review